Stanton Glantz blog

Commentary on tobacco, cannabis and public health

FDA bent over backwards to authorize sale of RJR’s Vuse Solo e-cig

On October 12, 2021, FDA authorized the sale of RJ Reynolds’ Vuse Solo e-cigarette. When I read the FDA’s Technical Project Lead summary of its scientific justification for authorizing the sale of RJ Reynolds’ Vuse Solo e-cigarette, I was struck by the fact that it ignored the broad scientific literature on e-cigarettes and seemed toContinue reading “FDA bent over backwards to authorize sale of RJR’s Vuse Solo e-cig”

Vaping exploding among New Zealand youth

Like their British cousins, most public health authorities in New Zealand have embraced e-cigarettes for harm reduction. In contrast to heavily regulated cigarettes (no advertising, plain packaging, graphic warning labels, no power walls, strong smokefree laws), e-cigs were introduced to New Zealand in around 2017 without any regulations on marketing and advertising no controls onContinue reading “Vaping exploding among New Zealand youth”

New meta-analysis confirms that e-cigs do not help smokers quit in the real world

Linnea Hedman and colleagues in Sweden just published a new meta-analysis of the relationship between e-cigarette use and smoking cessation, Electronic cigarette use and smoking cessation in cohort studies and randomized trials: A systematic review and meta-analysis. Like our earlier meta-analysis, did separate analyses of population-based observational studies and randomized trials of e-cigarettes provided asContinue reading “New meta-analysis confirms that e-cigs do not help smokers quit in the real world”

World Heart Federation highlights cardiovascular risks of e-cigs, calls for strict regulation, supports countries with bans

On October 18, 2021 the World Heart Federation released a policy brief “E-cigarettes: A new threat to cardiovascular health,” (press release) that provides an overview of the evidence that e-cigarette use has a wide range of adverse effects on the cardiovascular system that are reflected as an increased risk of heart attack at a populationContinue reading “World Heart Federation highlights cardiovascular risks of e-cigs, calls for strict regulation, supports countries with bans”

Science FDA (and everyone else) needs to actively engage as they think about whether to authorize Juul and the other ecigs

When I read the FDA’s Technical Project Lead summary of its scientific justification for authorizing the sale of RJ Reynolds’ Vuse Solo e-cigarette, I was struck by the fact that it ignored the broad scientific literature on e-cigarettes and seemed to accept industry-framed arguments. For example: They ignored the evidence that as consumer products, e-cigarettesContinue reading “Science FDA (and everyone else) needs to actively engage as they think about whether to authorize Juul and the other ecigs”

FCTC stimulated smoking bans and pictorial warnings but not tax increases or ad bans

The WHO Framework Convention on Tobacco Control (FCTC) committed Parties to, among other things, implement tobacco demand reduction measures including smokefree laws, strong health warning labels and increase tobacco taxes. Previous studies, including some of our work, have generally shown that countries followed treaty ratification by implementing at least some of these policies. Now HeikkiContinue reading “FCTC stimulated smoking bans and pictorial warnings but not tax increases or ad bans”

E-cigarettes don’t help smokers stay off cigarettes

Last week the FDA authorized the sale of RJ Reynolds’ (BAT’s US subsidiary) Vuse e-cigarette despite heavy use by kids because “the manufacturer’s data demonstrates its tobacco-flavored products could benefit addicted adult smokers who switch to these products – either completely or with a significant reduction in cigarette consumption – by reducing their exposure toContinue reading “E-cigarettes don’t help smokers stay off cigarettes”

PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims

My UCSF TCORS colleagues and I submitted this public comment to the FDA opposing Philip Morris’ application for authorization for them to make modified risk claims for its new IQOS 3 heated tobacco product. A PDF of the comment is here. The Regulations.gov tracking number is kur-iypq-uf1v. Here is the comment: The supplemental modified riskContinue reading “PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims”

Loading…

Something went wrong. Please refresh the page and/or try again.


Follow My Blog

Get new content delivered directly to your inbox.

%d bloggers like this: